Vical Inc. Launches Corporate Website to Democratize Company Information

Vical Inc., a biopharmaceutical company focused on the development of gene-based pharmaceutical product candidates, has launched a corporate website to provide easy access to detailed information for its various constituencies. The website, vical.com, contains sections for investors, research scientists, clinical trial participants, potential employees, and business affiliates. The site includes corporate information, financial information, news and publications, clinical trial information, and descriptions of Vical's technology. According to Alain B. Schreiber, M.D., president and chief executive officer of Vical, the company remains committed to the broad and timely release of information and views the internet as a medium that can help democratize that process.

Key Takeaways:

• Vical Inc. has launched a corporate website at vical.com to provide easy access to detailed information for various constituencies, including investors, research scientists, clinical trial participants, potential employees, and business affiliates.
• The website contains sections for corporate information, financial information, news and publications, clinical trial information, and descriptions of Vical's technology.
• Alain B. Schreiber, M.D., president and chief executive officer of Vical, stated that the company remains committed to the broad and timely release of information and views the internet as a medium that can help democratize that process.
• Vical Inc. is focused on the development of gene-based pharmaceutical product candidates for the prevention or treatment of cancer, infectious diseases, and metabolic disorders.
• The company has several product candidates under development, including Allovectin-7, Leuvectin, and Vaxid, which are being tested in various phases of clinical trials.
• Vical has collaborative partnerships with several major pharmaceutical companies, including Merck, Pasteur Merieux Connaught, Rhone-Poulenc Rorer, Centocor, and Genzyme.

Statistics:

• The website vical.com is accessible for easy access to detailed information about Vical Inc.
• The company has multiple product candidates under development, including Allovectin-7, Leuvectin, and Vaxid.
• Vical Inc. has collaborative partnerships with several major pharmaceutical companies, including Merck, Pasteur Merieux Connaught, Rhone-Poulenc Rorer, Centocor, and Genzyme.
• Alain B. Schreiber, M.D., is the president and chief executive officer of Vical Inc.

Sources:

• "Vical Inc. Announces Launch of Corporate Website", Vical Inc. Press Release, October 6, 1998.
• Securities and Exchange Commission filings of Vical Inc.
• Interview with Alain B. Schreiber, M.D., president and chief executive officer of Vical Inc.